defb2 Search Results


serum beta 2 microglobulin level  (Shanghai Korain Biotech Co Ltd)
94
Shanghai Korain Biotech Co Ltd serum beta 2 microglobulin level
Comparison of <t> serum beta-2 microglobulin </t> levels in case–control group.
Serum Beta 2 Microglobulin Level, supplied by Shanghai Korain Biotech Co Ltd, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/serum beta 2 microglobulin level/product/Shanghai Korain Biotech Co Ltd
Average 94 stars, based on 1 article reviews
serum beta 2 microglobulin level - by Bioz Stars, 2026-06
94/100 stars
  Buy from Supplier
mouse b-defensin-3 mbd-3 mm01614469_m1  (Thermo Fisher)
90
Thermo Fisher mouse b-defensin-3 mbd-3 mm01614469_m1
Comparison of <t> serum beta-2 microglobulin </t> levels in case–control group.
Mouse B Defensin 3 Mbd 3 Mm01614469 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse b-defensin-3 mbd-3 mm01614469_m1/product/Thermo Fisher
Average 90 stars, based on 1 article reviews
mouse b-defensin-3 mbd-3 mm01614469_m1 - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
hbd 2 elisa kit  (Elabscience Biotechnology)
92
Elabscience Biotechnology hbd 2 elisa kit
Comparison of <t> serum beta-2 microglobulin </t> levels in case–control group.
Hbd 2 Elisa Kit, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hbd 2 elisa kit/product/Elabscience Biotechnology
Average 92 stars, based on 1 article reviews
hbd 2 elisa kit - by Bioz Stars, 2026-06
92/100 stars
  Buy from Supplier
defb4  (OriGene)
80
OriGene defb4
IL-1β treatment induces the expression of hBD2 in keratinocytes, a soluble factor that protects against V8 protease-mediated damage. ( a ) HaCaT (n = 9) or HPEK (n = 3) cells treated with conditioned media (transferred from control or IL-1β [100 ng/ml] pretreated cells) were exposed to recombinant V8 protease for 24 hours before quantification of damage. ( b–f ) HaCaT or HPEK cells treated for 24 hours or ( e ) over a time course with control (media only), IL-1β (100 ng/ml), LTA (10 μg/ml), LPS (5 μg/ml), or heat-killed Staphylococcus epidermidis, then assessed by ( b ) real-time reverse transcriptase PCR for expression of <t>DEFB4</t> , DEFB1 , ( c, e, f ) ELISA for hBD2, and ( d ) quantification of V8-induced damage. Data show mean ± standard error of the mean. ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001 versus control. CM, conditioned media; HKSE, heat-killed S. epidermidis ; HPEK, human primary epidermal keratinocyte; LPS, lipopolysaccharide; LTA, lipoteichoic acid; NS, not significant.
Defb4, supplied by OriGene, used in various techniques. Bioz Stars score: 80/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/defb4/product/OriGene
Average 80 stars, based on 1 article reviews
defb4 - by Bioz Stars, 2026-06
80/100 stars
  Buy from Supplier
plasmid defb2  (GenScript corporation)
90
GenScript corporation plasmid defb2
IL-1β treatment induces the expression of hBD2 in keratinocytes, a soluble factor that protects against V8 protease-mediated damage. ( a ) HaCaT (n = 9) or HPEK (n = 3) cells treated with conditioned media (transferred from control or IL-1β [100 ng/ml] pretreated cells) were exposed to recombinant V8 protease for 24 hours before quantification of damage. ( b–f ) HaCaT or HPEK cells treated for 24 hours or ( e ) over a time course with control (media only), IL-1β (100 ng/ml), LTA (10 μg/ml), LPS (5 μg/ml), or heat-killed Staphylococcus epidermidis, then assessed by ( b ) real-time reverse transcriptase PCR for expression of <t>DEFB4</t> , DEFB1 , ( c, e, f ) ELISA for hBD2, and ( d ) quantification of V8-induced damage. Data show mean ± standard error of the mean. ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001 versus control. CM, conditioned media; HKSE, heat-killed S. epidermidis ; HPEK, human primary epidermal keratinocyte; LPS, lipopolysaccharide; LTA, lipoteichoic acid; NS, not significant.
Plasmid Defb2, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/plasmid defb2/product/GenScript corporation
Average 90 stars, based on 1 article reviews
plasmid defb2 - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
defb2 enzyme-linked immunosorbent assay (elisa) development kit  (PeproTech)
90
PeproTech defb2 enzyme-linked immunosorbent assay (elisa) development kit
IL-1β treatment induces the expression of hBD2 in keratinocytes, a soluble factor that protects against V8 protease-mediated damage. ( a ) HaCaT (n = 9) or HPEK (n = 3) cells treated with conditioned media (transferred from control or IL-1β [100 ng/ml] pretreated cells) were exposed to recombinant V8 protease for 24 hours before quantification of damage. ( b–f ) HaCaT or HPEK cells treated for 24 hours or ( e ) over a time course with control (media only), IL-1β (100 ng/ml), LTA (10 μg/ml), LPS (5 μg/ml), or heat-killed Staphylococcus epidermidis, then assessed by ( b ) real-time reverse transcriptase PCR for expression of <t>DEFB4</t> , DEFB1 , ( c, e, f ) ELISA for hBD2, and ( d ) quantification of V8-induced damage. Data show mean ± standard error of the mean. ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001 versus control. CM, conditioned media; HKSE, heat-killed S. epidermidis ; HPEK, human primary epidermal keratinocyte; LPS, lipopolysaccharide; LTA, lipoteichoic acid; NS, not significant.
Defb2 Enzyme Linked Immunosorbent Assay (Elisa) Development Kit, supplied by PeproTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/defb2 enzyme-linked immunosorbent assay (elisa) development kit/product/PeproTech
Average 90 stars, based on 1 article reviews
defb2 enzyme-linked immunosorbent assay (elisa) development kit - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
β defensin def β2 levels  (Elabscience Biotechnology)
92
Elabscience Biotechnology β defensin def β2 levels
IL-1β treatment induces the expression of hBD2 in keratinocytes, a soluble factor that protects against V8 protease-mediated damage. ( a ) HaCaT (n = 9) or HPEK (n = 3) cells treated with conditioned media (transferred from control or IL-1β [100 ng/ml] pretreated cells) were exposed to recombinant V8 protease for 24 hours before quantification of damage. ( b–f ) HaCaT or HPEK cells treated for 24 hours or ( e ) over a time course with control (media only), IL-1β (100 ng/ml), LTA (10 μg/ml), LPS (5 μg/ml), or heat-killed Staphylococcus epidermidis, then assessed by ( b ) real-time reverse transcriptase PCR for expression of <t>DEFB4</t> , DEFB1 , ( c, e, f ) ELISA for hBD2, and ( d ) quantification of V8-induced damage. Data show mean ± standard error of the mean. ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001 versus control. CM, conditioned media; HKSE, heat-killed S. epidermidis ; HPEK, human primary epidermal keratinocyte; LPS, lipopolysaccharide; LTA, lipoteichoic acid; NS, not significant.
β Defensin Def β2 Levels, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/β defensin def β2 levels/product/Elabscience Biotechnology
Average 92 stars, based on 1 article reviews
β defensin def β2 levels - by Bioz Stars, 2026-06
92/100 stars
  Buy from Supplier
rabbit anti-β-defensin-2 (defb2) antibody  (GeneTex)
90
GeneTex rabbit anti-β-defensin-2 (defb2) antibody
IL-1β treatment induces the expression of hBD2 in keratinocytes, a soluble factor that protects against V8 protease-mediated damage. ( a ) HaCaT (n = 9) or HPEK (n = 3) cells treated with conditioned media (transferred from control or IL-1β [100 ng/ml] pretreated cells) were exposed to recombinant V8 protease for 24 hours before quantification of damage. ( b–f ) HaCaT or HPEK cells treated for 24 hours or ( e ) over a time course with control (media only), IL-1β (100 ng/ml), LTA (10 μg/ml), LPS (5 μg/ml), or heat-killed Staphylococcus epidermidis, then assessed by ( b ) real-time reverse transcriptase PCR for expression of <t>DEFB4</t> , DEFB1 , ( c, e, f ) ELISA for hBD2, and ( d ) quantification of V8-induced damage. Data show mean ± standard error of the mean. ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001 versus control. CM, conditioned media; HKSE, heat-killed S. epidermidis ; HPEK, human primary epidermal keratinocyte; LPS, lipopolysaccharide; LTA, lipoteichoic acid; NS, not significant.
Rabbit Anti β Defensin 2 (Defb2) Antibody, supplied by GeneTex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti-β-defensin-2 (defb2) antibody/product/GeneTex
Average 90 stars, based on 1 article reviews
rabbit anti-β-defensin-2 (defb2) antibody - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
defb2 rat shrna plasmid  (OriGene)
N/A
Defb2 Rat 4 unique 29mer shRNA constructs in retroviral untagged vector
   Buy from Supplier
defb2, murine  (Gold Biotechnology Inc)
N/A
GoldBio growth factors are manufactured for RESEARCH USE ONLY and cannot be sold for human consumption! Recombinant Murine Defensin, Beta 2 BD2, DEFB-2, MBD-2 Murine beta-defensin 2 (DEFB2) is an antimicrobial peptide that contributes to
   Buy from Supplier
defb2 mouse gene knockout kit  (OriGene)
N/A
Defb2 KN2 0 Mouse gene knockout kit via CRISPR non homology mediated
   Buy from Supplier
defb2 nm 001037507 rat tagged orf clone  (OriGene)
N/A
Defb2 Myc DDK tagged ORF Rat defensin beta 2 Defb2 10 ug
   Buy from Supplier

Image Search Results


Comparison of serum beta-2 microglobulin levels in case–control group.

Journal: Medicina

Article Title: Low Serum Beta-2 Microglobulin Level: A Possible Biomarker for Sarcopenia in the Elderly Population

doi: 10.3390/medicina60111879

Figure Lengend Snippet: Comparison of serum beta-2 microglobulin levels in case–control group.

Article Snippet: Serum beta-2 microglobulin level was measured manually by a sandwich enzyme-linked immunosorbent assay (ELISA) method with a BTLAB Mikroelisa test kit and measured according to the kit protocols.

Techniques: Comparison

Area under curve for beta-2 microglobulin.

Journal: Medicina

Article Title: Low Serum Beta-2 Microglobulin Level: A Possible Biomarker for Sarcopenia in the Elderly Population

doi: 10.3390/medicina60111879

Figure Lengend Snippet: Area under curve for beta-2 microglobulin.

Article Snippet: Serum beta-2 microglobulin level was measured manually by a sandwich enzyme-linked immunosorbent assay (ELISA) method with a BTLAB Mikroelisa test kit and measured according to the kit protocols.

Techniques:

Serum beta-2 microglobulin level metrics for different cut-offs.

Journal: Medicina

Article Title: Low Serum Beta-2 Microglobulin Level: A Possible Biomarker for Sarcopenia in the Elderly Population

doi: 10.3390/medicina60111879

Figure Lengend Snippet: Serum beta-2 microglobulin level metrics for different cut-offs.

Article Snippet: Serum beta-2 microglobulin level was measured manually by a sandwich enzyme-linked immunosorbent assay (ELISA) method with a BTLAB Mikroelisa test kit and measured according to the kit protocols.

Techniques:

Logistic regression analysis of sarcopenia risk.

Journal: Medicina

Article Title: Low Serum Beta-2 Microglobulin Level: A Possible Biomarker for Sarcopenia in the Elderly Population

doi: 10.3390/medicina60111879

Figure Lengend Snippet: Logistic regression analysis of sarcopenia risk.

Article Snippet: Serum beta-2 microglobulin level was measured manually by a sandwich enzyme-linked immunosorbent assay (ELISA) method with a BTLAB Mikroelisa test kit and measured according to the kit protocols.

Techniques:

IL-1β treatment induces the expression of hBD2 in keratinocytes, a soluble factor that protects against V8 protease-mediated damage. ( a ) HaCaT (n = 9) or HPEK (n = 3) cells treated with conditioned media (transferred from control or IL-1β [100 ng/ml] pretreated cells) were exposed to recombinant V8 protease for 24 hours before quantification of damage. ( b–f ) HaCaT or HPEK cells treated for 24 hours or ( e ) over a time course with control (media only), IL-1β (100 ng/ml), LTA (10 μg/ml), LPS (5 μg/ml), or heat-killed Staphylococcus epidermidis, then assessed by ( b ) real-time reverse transcriptase PCR for expression of DEFB4 , DEFB1 , ( c, e, f ) ELISA for hBD2, and ( d ) quantification of V8-induced damage. Data show mean ± standard error of the mean. ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001 versus control. CM, conditioned media; HKSE, heat-killed S. epidermidis ; HPEK, human primary epidermal keratinocyte; LPS, lipopolysaccharide; LTA, lipoteichoic acid; NS, not significant.

Journal: The Journal of Investigative Dermatology

Article Title: IL-1β–Induced Protection of Keratinocytes against Staphylococcus aureus -Secreted Proteases Is Mediated by Human β-Defensin 2

doi: 10.1016/j.jid.2016.08.025

Figure Lengend Snippet: IL-1β treatment induces the expression of hBD2 in keratinocytes, a soluble factor that protects against V8 protease-mediated damage. ( a ) HaCaT (n = 9) or HPEK (n = 3) cells treated with conditioned media (transferred from control or IL-1β [100 ng/ml] pretreated cells) were exposed to recombinant V8 protease for 24 hours before quantification of damage. ( b–f ) HaCaT or HPEK cells treated for 24 hours or ( e ) over a time course with control (media only), IL-1β (100 ng/ml), LTA (10 μg/ml), LPS (5 μg/ml), or heat-killed Staphylococcus epidermidis, then assessed by ( b ) real-time reverse transcriptase PCR for expression of DEFB4 , DEFB1 , ( c, e, f ) ELISA for hBD2, and ( d ) quantification of V8-induced damage. Data show mean ± standard error of the mean. ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001 versus control. CM, conditioned media; HKSE, heat-killed S. epidermidis ; HPEK, human primary epidermal keratinocyte; LPS, lipopolysaccharide; LTA, lipoteichoic acid; NS, not significant.

Article Snippet: Standard curves were performed using plasmids for DEFB1 , DEFB4 (Origene #SC116851, RC219487), and DEFB103 (generated by J. Dorin).

Techniques: Expressing, Recombinant, Enzyme-linked Immunosorbent Assay

hBD2 is sufficient and necessary to protect against V8 protease-mediated damage. ( a–e ) hBD2 overexpressing (hBD2 OE) and vector only (VO control) HaCaT or naive HaCaT preincubated with CM or ( f, g ) DEFB4 shRNA-knockdown and control shRNA HaCaT lines ± IL-1β prestimulation (100 ng/ml, 24 hours), assessed by ( a ) DEFB4 quantitative real-time reverse transcriptase–PCR (n = 3), ( b, f ) hBD2 ELISA (n = 5–7), ( c, d, g ) V8-mediated damage quantification (n = 3–4), and ( e ) quantified Western blot ± V8 pre-exposure (3 μg/ml, 24 hours). ( h, i ) HaCaT or HPEK pretreated with distilled water, recombinant (3 μg/ml), scrambled ( h : 3 μg/ml, i : 6 μg/ml), or synthetic hBD2 ( h : 3 μg/ml, i : 6 μg/ml ) 24 hours before V8 ( h : 24 hours, 3 μg/ml; i : 48 hours, 6 μg/ml). n = 3–5. Mean ± standard error of the mean. ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001. CM, conditioned media; hBD, human β-defensin; HPEK, human primary epidermal keratinocyte; OE, overexpressing; Recomb., recombinant; Scramb., scrambled; shRNA, small hairpin RNA; Synth, synthetic; VO, vector only.

Journal: The Journal of Investigative Dermatology

Article Title: IL-1β–Induced Protection of Keratinocytes against Staphylococcus aureus -Secreted Proteases Is Mediated by Human β-Defensin 2

doi: 10.1016/j.jid.2016.08.025

Figure Lengend Snippet: hBD2 is sufficient and necessary to protect against V8 protease-mediated damage. ( a–e ) hBD2 overexpressing (hBD2 OE) and vector only (VO control) HaCaT or naive HaCaT preincubated with CM or ( f, g ) DEFB4 shRNA-knockdown and control shRNA HaCaT lines ± IL-1β prestimulation (100 ng/ml, 24 hours), assessed by ( a ) DEFB4 quantitative real-time reverse transcriptase–PCR (n = 3), ( b, f ) hBD2 ELISA (n = 5–7), ( c, d, g ) V8-mediated damage quantification (n = 3–4), and ( e ) quantified Western blot ± V8 pre-exposure (3 μg/ml, 24 hours). ( h, i ) HaCaT or HPEK pretreated with distilled water, recombinant (3 μg/ml), scrambled ( h : 3 μg/ml, i : 6 μg/ml), or synthetic hBD2 ( h : 3 μg/ml, i : 6 μg/ml ) 24 hours before V8 ( h : 24 hours, 3 μg/ml; i : 48 hours, 6 μg/ml). n = 3–5. Mean ± standard error of the mean. ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001. CM, conditioned media; hBD, human β-defensin; HPEK, human primary epidermal keratinocyte; OE, overexpressing; Recomb., recombinant; Scramb., scrambled; shRNA, small hairpin RNA; Synth, synthetic; VO, vector only.

Article Snippet: Standard curves were performed using plasmids for DEFB1 , DEFB4 (Origene #SC116851, RC219487), and DEFB103 (generated by J. Dorin).

Techniques: Plasmid Preparation, shRNA, Enzyme-linked Immunosorbent Assay, Western Blot, Recombinant